Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 64,000
Avg Vol 19,076
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 65%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis;...

Industry: Biotechnology
Sector: Healthcare
Phone: 902 450 1588
Fax: 877 633 6372
Website: medmira.com
Address:
155 Chain Lake Drive, Suite 1, Halifax, Canada
Latest News on MMIRF
No data available.